Want to join the conversation?
$K expects the Parati deal to be neutral to comparable-basis EPS in 2016 and 2017, with only a slight negative impact on reported EPS because of one-time costs of $0.01 per share in both years. The deal is expected to be accretive on both comparable and reported EPS in 2018 and thereafter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?